Page last updated: 2024-08-16

4-nitrobenzylthioinosine and Atypical Mycobacterial Infection, Disseminated

4-nitrobenzylthioinosine has been researched along with Atypical Mycobacterial Infection, Disseminated in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Aragaw, WW; Barros-Aguirre, D; Cacho-Izquierdo, M; Dartois, V; Del Río, RG; Dick, T; Ganapathy, US; Gengenbacher, M; Lelièvre, J; Lindman, M; Ortega, F; Zimmerman, MD1

Other Studies

1 other study(ies) available for 4-nitrobenzylthioinosine and Atypical Mycobacterial Infection, Disseminated

ArticleYear
A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
    Antimicrobial agents and chemotherapy, 2021, 11-17, Volume: 65, Issue:12

    Topics: Animals; Mice; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Thioinosine; Topoisomerase II Inhibitors

2021